Abstract:We have recently shown that hepcidin expression undergoes a significant down regulation in the liver of a thalassaemia intermedia mouse model (TIM) C57Bl/6 Hbb th3/+ . (Adamsky K. et al. BJH2004 ; 124 (1): 123 –4 ). We extended these studies to a b-thalassemia major mouse model (TMM) generated via engraftment with beta-globin-null (Hbb th3 / th3 ) fetal liver cells. The resulting phenotype displayed considerably more severe symptoms than the TIM: the TMM succumbed to ineffective erythropoiesis within 60 days, developed massive splenomegaly, severe anemia, extramedullary hematopoiesis and hepatic iron overload. The expression levels of various iron metabolism-related genes (normalized to b-actin) were analyzed by quantitative RT-PCR on RNA extracted from the livers of adult mice. When compared to wild-type (WT) C57Bl/6 mice, the liver mRNA expression levels of TMM were markedly reduced for hepcidin and TfR2 (16 and 3 fold respectively), markedly increased for the lipocalin NGAL and transferrin receptor 1 (TfR1) (2.7 and 3.6 fold respectively), moderately increased for the ferroportin transporter (IREG1) (1.4 fold) and unaltered for the hemochromatosis gene (HFE). A possible mechanism that could explain the decreased expression of liver hepcidin in thalassaemia is one based on a putative regulatory serum factor that is associated with enhanced erythropoietic activity. In order to assess this hypothesis we compared the hepcidin inductive capacity of sera from iron-overloaded patients that either had or had not enhanced erythropoiesis, namely thalassemia and hemochromatosis, respectively. These included the following individuals: 14 with β-thalassemia major, 22 with hereditary hemochromatosis (HFE 282C mutation) and 3 healthy. The human sera were analyzed in terms of their capacity to modulate expression of iron-related genes in human hepatoma HepG2 cells, using quantitative RT-PCR. Hepcidin expression evoked by thalassemic sera was an average of 3 fold lower than that evoked by normal human serum, whereas hemochromatotic sera evoked an average of 7.83 fold increase. The down regulating effect of thalassemic sera on hepcidin expression, suggests the possible involvement of an upstream factor whose serum levels might increase in thalassemia due to ineffective erythropoiesis, i.e. an “erythropoietic regulator”. The effect of such an “erythropoietic regulator” is assumed to override the expected increase in hepcidin expression that results from the “stores regulator” which is responsive to iron overload such as in hemochromatosis (where there is no ineffective erythropoiesis). The reduced hepcidin expression found in thalassaemia might explain the increased enteric iron absorption whose extent could be moderated either by factors that increase hepcidin expression or by administration of hepcidin itself.

Hepcidin-to-ferritin ratio: A potential novel index to predict iron overload-liver fibrosis in ß-thalassemia major

The Diagnostic Value of the Fib-4 Index for Staging Hepatitis B-Related Fibrosis: A Meta-Analysis

Iron overload correlates with serum liver fibrotic markers and liver dysfunction: Potential new methods to predict iron overload-related liver fibrosis in thalassemia patients

Determination of Serum Fibrosis Indexes in Patients with Chronic Hepatitis and Its Significance

Optimized serum ferritin prediction of iron overload in transfusion-dependent thalassemia: likelihood ratio and age-adjustment approach

Multiple Regression Analysis of Liver Pathology and Other Factors in Children with Β Thalassemia Major

Serum Ferritin Levels Correlation With Heart and Liver MRI and LIC in Patients With Transfusion-Dependent Thalassemia

[The Diagnostic Value of Eight Serum Indices for Liver Fibrosis].

Hepcidin and HFE Polymorphisms and Ferritin Level in β-Thalassemia Major

[Diagnostic Values of Serum Levels of HA, PC III, C IV and LN to the Liver Fibrosis in Children with Beta-Thalassemia Major].

Noninvasive Assessment of Liver Fibrosis with Combined Serum Aminotransferase/platelet Ratio Index and Hyaluronic Acid in Patients with Chronic Hepatitis B.

Role of Hyaluronic Acid and Laminin As Serum Markers for Predicting Significant Fibrosis in Patients with Chronic Hepatitis B.

Rdw To Platelet Ratio: A Novel Noninvasive Index For Predicting Hepatic Fibrosis And Cirrhosis In Chronic Hepatitis B

Hepcidin Expression in Cultured Liver Cells Responds Differently to Iron Overloaded Sera Derived from Patients with Thalassemia and Hemochromatosis.

Interrelationship between liver T2*-weighted magnetic resonance imaging and acoustic radiation force impulse elastography measurement results and plasma ferritin levels in children with β-thalassemia major

Evaluation of the aspartate aminotransferase/platelet ratio index and enhanced liver fibrosis tests to detect significant fibrosis due to chronic hepatitis C.

Serum ferritin levels are associated with advanced liver fibrosis in treatment-naive autoimmune hepatitis

Hepcidin as a diagnostic biomarker of iron deficiency anemia during pregnancy

A Novel Noninvasive Index for the Prediction of Moderate to Severe Fibrosis in Chronic Hepatitis B Patients

Iron overload and liver function in patients with beta thalassemia major: A cross sectional study

Ferritin/alanine aminotransferase ratio as a possible marker for predicting the prognosis of acute liver injury